tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Annexon Biosciences outlines pivotal 2026 milestones and outlook
PremiumCompany AnnouncementsAnnexon Biosciences outlines pivotal 2026 milestones and outlook
2M ago
Annexon submits MAA to EMA for tanruprubart
Premium
The Fly
Annexon submits MAA to EMA for tanruprubart
2M ago
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
Premium
Weekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
3M ago
Annexon price target lowered to $8 from $9 at BofA
PremiumThe FlyAnnexon price target lowered to $8 from $9 at BofA
4M ago
Annexon Biosciences Completes Successful Public Offering
Premium
Company Announcements
Annexon Biosciences Completes Successful Public Offering
4M ago
Annexon 25.1M share Spot Secondary priced at $2.60
Premium
The Fly
Annexon 25.1M share Spot Secondary priced at $2.60
4M ago
Annexon reports Q3 EPS (37c), consensus (34c)
PremiumThe FlyAnnexon reports Q3 EPS (37c), consensus (34c)
4M ago
ANNX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANNX Upcoming Earnings Report: What to Expect?
4M ago
Annexon Biosciences’ New Study on Tanruprubart for Guillain-Barré Syndrome: A Potential Game-Changer?
Premium
Company Announcements
Annexon Biosciences’ New Study on Tanruprubart for Guillain-Barré Syndrome: A Potential Game-Changer?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100